Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 44 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 9974796

    Inhibitors of the plasmodial surface anion channel as antimalarials

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 22, 2018 · Expires May 17, 2038

    granted
  2. US 9975878

    Substituted triazine BMI-1 inhibitors

    PTC THERAPEUTICS, INC. · Granted May 22, 2018 · Expires May 17, 2038

    granted
  3. US 9962377

    Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors

    TAKEDA GMBH · Granted May 8, 2018 · Expires May 3, 2038

    granted
  4. US 9962379

    Inhibitors of the FKBP51 protein from a high-throughput drug screen and methods of use

    United States Government as represented by the Department of Veterans Affairs · Granted May 8, 2018 · Expires May 3, 2038

    granted
  5. US 9957259

    Selective HDAC1 and HDAC2 inhibitors

    Regenacy Pharmaceuticals, Inc. · Granted May 1, 2018 · Expires Apr 26, 2038

    granted
  6. US 9956215

    Methods of treating cancer with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted May 1, 2018 · Expires Apr 26, 2038

    granted
  7. US 9957281

    Benzodiazepine derivatives as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted May 1, 2018 · Expires Apr 26, 2038

    granted
  8. US 9957329

    Factor XII inhibitors for the treatment of neurological inflammatory disorders

    Julius-Maximilians-Universitat Wurzburg · Granted May 1, 2018 · Expires Apr 26, 2038

    granted
  9. US 9951078

    Inhibitors of ERK and methods of use

    Kura Oncology, Inc. · Granted Apr 24, 2018 · Expires Apr 19, 2038

    granted
  10. US 9949932

    Formulation of syk inhibitors

    GILEAD CONNECTICUT, INC. · Granted Apr 24, 2018 · Expires Apr 19, 2038

    granted
  11. US 9951014

    Mammalian and bacterial nitric oxide synthase inhibitors

    Northwestern University · Granted Apr 24, 2018 · Expires Apr 19, 2038

    granted
  12. US 9944626

    6-(5-hydroxy-1H-pyrazol-1-YL)nicotinamide inhibitors of PHD

    Takeda Pharmaceutical Company Limited · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted
  13. US 9937157

    Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted
  14. US 9937155

    Methods of use for trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors

    Aurigene Discovery Technologies Limited · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted
  15. US 9937228

    Treatment of myocardial infarction by inhibiting the action of mAKAPβ

    Anchored RSK3 Inhibitors, LLC · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted
  16. US 9931340

    Pyridazinone compounds and their use as DAAO inhibitors

    Takeda Pharmaceutical Company Limited · Granted Apr 3, 2018 · Expires Mar 29, 2038

    granted
  17. US 9925188

    DNA-PK inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted
  18. US 9918983

    Suicidal LSD1 inhibitors targeting SOX2-expressing cancer cells

    THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  19. US 9918939

    Formulation of Syk inhibitors

    GILEAD CONNECTICUT, INC. · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  20. US 9913843

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted
  21. US 9914723

    Small molecule inhibitors of Mcl-1 and uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted
  22. US 9908899

    Histone deacetylase inhibitors

    BIOMARIN PHARMACEUTICAL INC. · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted
  23. US 9908878

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted
  24. US 2018051034

    KV1.3 INHIBITORS AND THEIR MEDICAL APPLICATION

    4SC AG [DE] · Granted Feb 22, 2018 · Expires Feb 17, 2038

    granted